Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline updateJulia Bohlius, Alejandro Lazo‐Langner, Massimo Martino et al.|Blood Advances|2019Cited by 165
Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline UpdateJulia Bohlius, Alejandro Lazo‐Langner, Kari Bohlke et al.|Journal of Clinical Oncology|2019Cited by 152
Reduction in transmission of hepatitis C after the introduction of a heat‐treatment step in the production of C1‐inhibitor concentrateMarco Cicardi, A Agostoni, Pier Mannuccio Mannucci et al.|Transfusion|1995Cited by 53
Thromboembolic Complications in Malignant Haematological DisordersRoberto Castelli, A Guariglia, Barbara Ferrari et al.|Current Vascular Pharmacology|2010Cited by 39
Discrepancies between bone marrow histopathology and clinical phenotype in BCR-ABL1-negative myeloproliferative neoplasms associated with splanchnic vein thrombosisUmberto Gianelli, Silvano Bòsari, Alessandra Iurlo et al.|Leukemia Research|2015Cited by 19